Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M7MR
|
|||
| Former ID |
DIB010184
|
|||
| Drug Name |
Multivalent carbohydrate-based vaccine
|
|||
| Synonyms |
Multivalent carbohydrate-based vaccine (cancer); Heptavalent antigen-keyhole limpet hemocyanin plus QS21vaccine (cancer), MKSCC; Multivalent carbohydrate-based vaccine (cancer), Memorial Sloan-Kettering; Unimolecular penta-antigenic carbohydrate vaccine program (cancer), Memorial Sloan-Kettering CancerCenter; Globo H-Ley-STn-TF-Tn-KLH vaccine; Globo-H-Lewis Y-Tn-sTn-fucosyl GM1-GM2-polysialic acid-Tf multivalent vaccine, MSKCC
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Company |
Memorial Sloan-Kettering Cancer Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience. Expert Rev Vaccines. 2009 Oct;8(10):1399-413. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.